The use of physical and animal models to assess bioavailability

Pharmacology

Volumn 8, Issue 1-3, 1972, Pages 55-101

  Barr, W H ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DRUG; SALICYLAMIDE DERIVATIVE; TETRACYCLINE;

ABSORPTION; ANIMAL; DOG; DRUG DOSAGE FORM; GUINEA PIG; HAPLORHINI; HUMAN; IN VITRO STUDY; INSTRUMENTATION; INTESTINE ABSORPTION; KINETICS; METABOLISM; MOUSE; PARTICLE SIZE; PH; PHARMACEUTICS; RAT; REST; REVIEW; SOLUBILITY; STANDARD; STOMACH; SWINE; THEORETICAL MODEL; TIME;

ABSORPTION; ANIMAL; ASPIRIN; BIOPHARMACEUTICS; DOGS; DOSAGE FORMS; GUINEA PIGS; HAPLORHINI; HUMAN; HYDROGEN-ION CONCENTRATION; IN VITRO; INTESTINAL ABSORPTION; KINETICS; MICE; MODELS, THEORETICAL; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; RATS; REST; SALICYLAMIDES; SOLUBILITY; STOMACH; SWINE; TETRACYCLINE; TIME FACTORS;

EID: 0015462452     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000136327     Document Type: Article

References (106)

1. Crane, R.K. and Wilson, T.H.: J. appl. Physiol. 12: 145 (1958).
2. Shanker, L.S. and Tocco, D.J.: J. Pharmacol, exp. Ther. 123: 8 (1960).
3. Aguiar, A.J. and Fifelski, R.J.: J. pharm. Sci. 55.' 1387 (1966).
4. Taraszka, M.J.: J. pharm. Sci. 60: 946 (1971).
5. Reuning, R. and Levy, G.: J. pharm. Sci. 57: 1335 (1968).
6. Aguiar, A.: Drug Inform. Bull. 3: 17 (1969).
7. Reuning, R. and Levy, G.: J. pharm. Sci. 57: 1342 (1968).
8. Feldman, S. and Gibaldi, M.: J. pharm. Sci. 58: 425 (1969).
9. Saski, W.: J. pharm. Sci. 57: 836 (1968).
10. Benet, L.Z.; Orr, J. M.; Turner, R.H., and Webb, H.S.: J. pharm. Sci. 60: 234 (1971).
11. Mayersohn, M. and Gibaldi, M.: J. pharm. Sci. 60: 225 (1971).
12. Strahl, N.: Kinetics and mechanisms of aryl acid transport across the rat intestine; Ph.D. thesis, Buffalo (1971).
13. Levy, G. and Angelino, N.J.: J. pharm. Sci. 57: 1449 (1968).
14. Strahl, N. and Barr, W.H.: J. pharm. Sci. 60: 278 (1971).
15. Barr, W.H. and Riegelman, S.: J. pharm. Sci. 59: 154 (1970).
16. Barr, W.H. and Riegelman, S.: J. pharm. Sci. 59: 164 (1970).
17. Feldman, S.; Salvino, M., and Gibaldi, M.: J. pharm. Sci. 59: 705 (1970).
18. Shanker, L.: J. med. Chem. 2: 343 (1970).
19. Hogben, C.A.M.; Tocco, D.J.; Brodie, B.B., and Schanker, L.: J. Pharmacol, exp. Therap. 125: 275 (1959).
20. Kakemi, K.; Arita, T.; Hori, R., and Konishi, K.: Chem. pharm. Bull. 15: 1534 (1967).
21. Shedle, H.P.: J. clin. Endocrin. Metab. 25: 1309 (1965).
22. Doluisio, J.T.; Bellups, N.F.; Dittert, L.W.; Sugita, E.J., and Swintowsky, J.V.: J. pharm. Sci. 58: 1196 (1969).
23. Ho, N.F.; Higuchi, W.I., and Doluisio, J.T.: To be published.
24. Oshenfarhrt, O. and Winne, D.: Life Sci. 7: 493 (1968).
25. Pindall, M.H.; Cull, K.M.; Doran, K.M., and Dickenson, H.L.: J. Pharmacol, exp. Ther. 125: 287(1959).
26. Sturtevant, FM.; Pauls, J.F., and Abrams: Toxicol, appl. Pharmacol. 3: 80 (1961).
27. Morozowich, W.; Chulski, T.; Hatnlin, W.E.; Jones, P.M.; Northam, J.I.; Purmalio, A., and Wagner, J.G.: J. pharm. Sci. 51: 993 (1962).
28. Dittert, L.; Adams, H.; Alexander, F.; Chong, C.; Ellison, T., and Swintowski, J. V.: J. pharm. Sci. 57: 1146 (1968).
29. Mullins, J. and Macek, T.J.: Amer. pharm. Ass. Sci. Ed. 49: 245 (1960).
30. Lee, C.; Froman, R.O.; Anderson, R.C., and Chen, K.K.: Antibiot. Chemother. N.Y. 8: 354 (1958).
31. Harris, P.A. and Riegelman, S.: J. pharm. Sci. 58: 71 (1969).
32. Synchowicz, S.; Zeman, W. V.; Williams, R.A., and Tabachnick, I.I.A.: Arch. int. Phar-macodyn. 158: 360 (1965).
33. Lackman, L.; Barrett, W.; Rinehard, R.K., and Sheppard, H.: Curr. Therap. Res. 6: 491 (1964).
34. Sample, R.G.; Rossi, G. V., and Packman, E. W. : J. pharm. Sci. 57: 795 (1968).
35. Poole, J.W.: Drug Inform. Bull. 3: 8 (1969).
36. Cressman, W.A.; Janicki, C.A.; Johnson, P.C.; Doluisio, J.T., and Braun, G.A.: J. pharm. Sci. 58: 1516 (1969).
37. J. pharm. Sci. 56 (1967).
38. Withey, R.: Symposium on ‘perspectives in bioavailability of drugs, therapeutic and toxicological significance Canad. Ass. Res. in Toxicology, Montreal 1971, and personal communication.
39. Weiner, M.: Paper presented to 1971 National Industrial Pharmaceutical Research Conference, ‘Drug absorption through the gastrointestinal barrier’, Land O’Lakes, Wise.
40. Aguiar, A.J.; Krc, J., Kinkel, A. W., and Samyn, J.C.: J. pharm. Sci. 56: 847 (1967).
41. Bauer, G.; Rieckman, P., and Schaumann: Arzneimittelforsch. 12: 487 (1962).
42. Kraml, M.; Dubuc, J., and Gaudry, R.: Antibiot. Chemother. N.Y. 12: 239 (1962).
43. Marvel et al: J. invest. Derm. 37: 1967 (1963).
44. Wagner, J.G.: Drug intelligence 3: 198, 224, 278, 324, 357 (1969).
45. Swarbrick, J. (ed.): Current concepts in the pharmaceutical sciences (Lea & Febiger, Philadelphia 1970).
46. Wood, J.: Pharm. Acta Helv. 42: 129 (1967).
47. Higuchi, T.: J. pharm. Sci. 56: 315 (1967).
48. Hersey, J.A.: MfgChem. 40: 32 (1969).
49. Fincher, J.: J. pharm. Sci. 57: 1825 (1968).
50. Wurster, D.E., and Taylor, P. W.: J. pharm. Sci. 54: 169 (1965).
51. Niebergall, P.J.; Milosovich, G., and Goyan, J.E.: J. pharm. Sci. 52: 236 (1963).
52. Higuchi, W.I.; Mir, N.A., and Desai, S.J.: J. pharm. Sci. 54: 1405 (1965).
53. Nelson, E.; Knolchel, E.L.; Hamlin, W.E., and Wagner, J.G.: J. pharm. Sci. 51: 509 (1962).
54. Nelson, E.: Chcm. pharm. Bull. JO: 1099 (1962).
55. Levy, G.; Antkowiak, J.M.; Prochnal, J.A., and White, D.C.: 52: 1047 (1963).
56. Wood, J.: J. pharm. Sci. 54: 1207 (1965).
57. Paikoff, M. and Drurnm, G.: J. pharm. Sci. 54: 1693 (1965).
58. Schroeter, L.C; Tingstad, J.E.; Koechel, E.L., and Wagner, J.G.: J. pharm. Sci. 51: 865 (1962).
59. Levy, G. and Hayes: New Engl. J. Med. 262: 1053 (1960).
60. Morrison, A.B. and Campbell: J. pharm. Sci. 54: 1 (1965).
61. Yen, J.K.C.: Canad. pharm. J. 97: 493 (1964).
62. Kildig: Proc. 5th Nat. Meet. APhA Acad. Pharm.Sci.,Washington,D.C.,1970, p.227.
63. Campagna, J., Cureton, G.; Mirigian, R., and Nelson, E.:J.pharm.Sci. 52:605 (1963).
64. Levy, G.: Lancet (1962).
65. Levy, G.: Canad. med. Ass. J. 90: 978 (1964).
66. Keller, W.: Pharmazie 15: 56 (1960).
67. Markus, A.: Proc. 5th Nat. Meet. APhA Acad. Pharm. Sci., Washington, D.C., 1970, p. 291.
68. United States Pharmacopeia XVIII, standards for hydrochlorthiazide, meprobamate, nitrofurantoin, prednisone, prednisolone, sulfisoxazole and tolbutamide.
69. National Formulary XVIII, standards for acetohexamide, methandrostenolone, sulfamethoxazole and methylprednisolone.
70. Barr, W.H.; Letcher, K., and Adir, J.: Abstracts of APhA Acad. Pharm. Sci. Ann. Meet., Washington, D.C., 1970.
71. Barr, W.H.; Adir, J., and Garrettson, L.: Clin. Pharmacol. Ther. 12: 779 (1971).
72. Nelson, E.: J. amer. pharm. Ass. (Sci. Ed.) 48: 96 (1959).
73. Macdonald, H.; Pisano, F.; Burger, J.; Dornbush, A., and Pelcak, E.: Drug Inform. Bull. 3: 76 (1969).
74. Barr, W.H.: Drug Inform. Bull. 3: 27 (1969).
75. Barr, W.H.; Gerbracht, L.; Letcher, K.; Plaut, M., and Strahl, N.R.: Clin. Pharmacol. Ther. (in press).
76. O'Reilly, R.A.; Nelson, E., and Levy, G.: J. pharm. Sci. 55: 435 (1966).
77. Riegelman, S.: Drug Inform. Bull. 3: 59 (1969).
78. Adir, J. and Barr, W.H.: To be published.
79. Krauer, B. and Dettli, L.: Chemotherapia 14: 1 (1969).
80. Dettli and Spring, P. : Helv. med. Acta 33: 291 (1966).
81. Levy, G.: J. pharm. Sci. 50: 181 (1969).
82. Bernard, B.; Yin, E.J., and Simon, H.J.: J. clin. Pharmacol. 11: 332 (1971).
83. Barr, W.H. and Riegelman, S.: To be published.
84. Levy, G. and Matsuzawa, J.J.: J. Pharmacol, exp. Ther. 156: 285 (1967).
85. Bates, T.R.; Iximbert, D.A., and Johns, W.H.: J. pharm. Sci. 58: 1468 (1969).
86. Barr, W.H.; Guzzo, G.; Aceto, T., and Garrettson, L.: Paper presented to the APhA Acad. Pharm. Sci., Washington, D.C., 1970.
87. Nelson, E.: J. amer. pharm. Ass. (Sci. Ed.) 47: 297 (1958).
88. Levy, G.: J. pharm. Sci. 52: 1039 (1963).
89. Ballard, B.E. and Biles, J.A.: Steroids 4: 273 (1964).
90. Levy, G. and Hayes, B.A.: New Engl. J. Med. 21: 1053 (1960).
91. Parrott, E.L.; Wurster, D.E., and Higuchi, T.: J. amer. pharm. Ass. (Sci. Ed.) 44: 269 (1955).
92. Wood, J., Syarto, J.E.; Syarto, L.C., and Herman, H.: J. pharm. Sci. 54: 1068 (1965).
93. Pernarowski, M.; Woo, W., and Searl, R.O.: J. pharm.Sci. 57: 1419(1968).
94. Cook, D.; Chang, H.S., and Mainville, C.A.: Canad. J.pharm. Sci.2:91(1966).
95. Gibaldi, M. and Weintraub, H.: J. pharm. Sci. 59: 725 (1970).
96. Braun, D.G. and Walker, G.C.: J. pharm. Sci. 58: 611 (1969).
97. Wagner, J.G.: Drug Intellig. and Clin. Pharm. 4: 232 (1970).
98. Levy, G.: J. pharm. Sci. 52: 1039 (1963).
99. Levy, G.: J. Mondial Pharm. (July-Sept.) 1967.
100. Weintraub, H. and Gibaldi, M.: J. pharm. Sci. 59: 1792 (1970).
101. Levy, G.: Arch. Int. Pharmacodyn. 152: 59(1964).
102. Levy and Hollister, L.E.: J. pharm. Sci. 53:1446(1964).
103. Levy, G., Leonards, J R., and Prochnal, J.A.: J. pharm. Sci. 54: 1719 (1965).
104. Levy, G.; Leonards, J.R., and Prochnal, J.A.: J. pharm. Sci. 56: 1365 (1967).
105. Levy, G.; Leonards, J.R., and Prochnal, J.A.: J. pharm. Sci. 56: 1365 (1967).
106. Levy, G.; Leonards, J.R., and Prochnal, J.A.: J. pharm. Sci. 56: 1365 (1967).